Protagenic Therapeutics, Inc. Share Price
Equities
PTIX
US74365N2027
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.385 USD | -11.71% | +7.36% | +39.90% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.39M 366M |
---|---|---|---|---|---|
Net income 2022 | -3M -250M | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net cash position 2022 | 7.63M 637M | Net cash position 2023 | 4.06M 338M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.94
x | P/E ratio 2023 |
-0.86
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.17% |
1 day | -11.71% | ||
1 week | +7.36% | ||
Current month | -20.86% | ||
1 month | -23.90% | ||
3 months | +55.60% | ||
6 months | +75.32% | ||
Current year | +39.90% |
Managers | Title | Age | Since |
---|---|---|---|
Alexander Arrow
DFI | Director of Finance/CFO | 53 | 01/16/01 |
Andrew Slee
COO | Chief Operating Officer | 74 | 01/16/01 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
FOU | Founder | 71 | 03/94/03 |
Robert Stein
CTO | Chief Tech/Sci/R&D Officer | 73 | 12/16/12 |
Brian Corvese
BRD | Director/Board Member | 67 | 28/17/28 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.385 | -11.71% | 10,467 |
25/24/25 | 1.569 | -4.23% | 16,676 |
24/24/24 | 1.638 | +4.33% | 6,507 |
23/24/23 | 1.57 | +25.60% | 71,418 |
22/24/22 | 1.25 | -3.10% | 7,533 |
Delayed Quote Nasdaq, April 27, 2024 at 02:00 am IST
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+39.90% | 6.14M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- PTIX Stock